Recent Quarter Total Invested
$94.14 M
Recent Quarter Institutional Ownership Percentage
51.61%
Total Invested of Last Quarter
$138.27 M
Ownership Percentage of Last Quarter
51.08%
Lineage Cell Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BROADWOOD CAPITAL INC | 08/14/2024 | 41.67 M | $41.55 M | 0.00% | 22.78% |
BLACKROCK INC. | 08/13/2024 | 9.56 M | $9.53 M | 12.54% | 5.23% |
VANGUARD GROUP INC | 08/13/2024 | 8.47 M | $8.45 M | 1.20% | 4.63% |
DEFENDER CAPITAL, LLC. | 07/29/2024 | 4.97 M | $4.96 M | 0.11% | 2.72% |
LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 4.70 M | $4.69 M | -24.80% | 2.57% |
RAFFLES ASSOCIATES LP | 08/14/2024 | 4.36 M | $4.35 M | 35.76% | 2.38% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 3.60 M | $3.59 M | 10.54% | 1.97% |
STATE STREET CORP | 08/14/2024 | 2.56 M | $2.56 M | 17.71% | 1.40% |
MAI CAPITAL MANAGEMENT | 08/12/2024 | 1.64 M | $1.63 M | 9.92% | 0.90% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.36 M | $1.36 M | 3.79% | 0.74% |
DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 1.35 M | $1.35 M | -1.14% | 0.74% |
NORTHERN TRUST CORP | 08/14/2024 | 1.19 M | $1.19 M | -3.34% | 0.65% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 681,766 | $679,925 | 0.00% | 0.37% |
ROYAL BANK OF CANADA | 08/14/2024 | 647,463 | $646,000 | 21,010.63% | 0.35% |
PRESCOTT GENERAL PARTNERS LLC | 08/14/2024 | 620,000 | $618,326 | -66.52% | 0.34% |
JPMORGAN CHASE & CO | 08/12/2024 | 594,298 | $592,693 | -12.05% | 0.32% |
RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 583,622 | $582,046 | 9.99% | 0.32% |
MORGAN STANLEY | 08/14/2024 | 526,629 | $525,206 | 14.81% | 0.29% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 515,445 | $514,054 | 0.00% | 0.28% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 435,958 | $434,781 | 35.73% | 0.24% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 416,415 | $415,291 | 13.79% | 0.23% |
COMERICA BANK | 08/15/2024 | 250,000 | $249,325 | -0.12% | 0.14% |
JANE STREET GROUP, LLC | 08/15/2024 | 242,955 | $242,299 | 131.83% | 0.13% |
LONG FOCUS CAPITAL MANAGEMENT, LLC | 08/14/2024 | 215,000 | $214,420 | 0.00% | 0.12% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 207,764 | $207,203 | 0.74% | 0.11% |
MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 168,978 | $168,522 | 305.24% | 0.09% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 165,394 | $164,000 | 2.53% | 0.09% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 164,584 | $164,140 | 519.81% | 0.09% |
D. E. SHAW & CO., INC. | 08/14/2024 | 146,191 | $145,796 | -21.67% | 0.08% |
RHUMBLINE ADVISERS | 08/01/2024 | 132,491 | $132,087 | 15.13% | 0.07% |
DCF ADVISERS, LLC | 08/12/2024 | 107,751 | $107,460 | 0.00% | 0.06% |
WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 08/05/2024 | 101,300 | $101,026 | 0.00% | 0.06% |
COREBRIDGE FINANCIAL, INC. | 08/14/2024 | 79,480 | $79,265 | 100.00% | 0.04% |
VIRTU FINANCIAL LLC | 08/09/2024 | 78,454 | $78,000 | 100.00% | 0.04% |
METLIFE INVESTMENT MANAGEMENT, LLC | 08/13/2024 | 78,181 | $77,970 | 12.15% | 0.04% |
UBS GROUP AG | 08/14/2024 | 76,466 | $76,237 | -45.41% | 0.04% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 71,322 | $71,130 | 102.02% | 0.04% |
QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 68,286 | $68,102 | 420.35% | 0.04% |
WELLS FARGO & COMPANY/MN | 08/13/2024 | 67,441 | $67,259 | 11.70% | 0.04% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2024 | 66,707 | $66,527 | 100.00% | 0.04% |
XTX TOPCO LTD | 08/12/2024 | 61,515 | $61,349 | 100.00% | 0.03% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 57,953 | $57,797 | -0.74% | 0.03% |
DEUTSCHE BANK AG\ | 08/14/2024 | 57,611 | $57,611 | -23.08% | 0.03% |
VOYA INVESTMENT MANAGEMENT LLC | 08/14/2024 | 56,786 | $56,633 | 18.72% | 0.03% |
INVESCO LTD. | 08/13/2024 | 56,764 | $56,611 | 0.03% | 0.03% |
HIGHTOWER ADVISORS, LLC | 08/13/2024 | 55,671 | $56,000 | -12.97% | 0.03% |
UNITED BANK | 08/14/2024 | 52,000 | $51,861 | 23.81% | 0.03% |
BARCLAYS PLC | 08/14/2024 | 51,376 | $51,000 | -45.30% | 0.03% |
COMMONWEALTH EQUITY SERVICES, LLC | 07/31/2024 | 47,761 | $48,000 | 0.00% | 0.03% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 47,139 | $47,017 | 2,158.70% | 0.03% |
Lineage Cell Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of LCTX shares?
During the previous two years, 138 institutional investors and hedge funds held shares of Lineage Cell Therapeutics, Inc.. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 41.67 M
BlackRock Inc.: 9.56 M
VANGUARD GROUP INC: 8.47 M
Defender Capital, LLC.: 4.97 M
Logos Global Management LP: 4.7 M
RAFFLES ASSOCIATES LP: 4.36 M
-
What percentage of Lineage Cell Therapeutics, Inc. stock is owned by institutional investors?
51.61% of Lineage Cell Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at LCTX ?
Institutional investors have bought a total of 94.85 M shares in the last 24 months. This purchase volume represents approximately $81.57 M in transactions.